The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oral adjuvant chemotherapy using uracil-tegafur (UFT) with leucovorin (LV) after resection of colorectal cancer liver metastases: Long-term survival results of the phase III UFT/LV study.
 
Kiyoshi Hasegawa
No Relationships to Disclose
 
Akio Saiura
No Relationships to Disclose
 
Tadatoshi Takayama
No Relationships to Disclose
 
Shinichi Miyagawa
No Relationships to Disclose
 
Junji Yamamoto
No Relationships to Disclose
 
Yasutsugu Bandai
No Relationships to Disclose
 
Masanori Teruya
No Relationships to Disclose
 
Fuyo Yoshimi
No Relationships to Disclose
 
Seiji Kawasaki
No Relationships to Disclose
 
Hiroto Koyama
No Relationships to Disclose
 
Masaru Oba
No Relationships to Disclose
 
Michiro Takahashi
No Relationships to Disclose
 
Suguru Yamashita
No Relationships to Disclose
 
Nobuyuki Mizunuma
No Relationships to Disclose
 
Yutaka Matsuyama
No Relationships to Disclose
 
Toshiaki Watanabe
No Relationships to Disclose
 
Masatoshi Makuuchi
No Relationships to Disclose
 
Norihiro Kokudo
Speakers' Bureau - Chugai Pharma; Merck Serono; Taiho Pharmaceutical